Parenchymal cell proliferation in coronary arteries after percutaneous transluminal coronary angioplasty: a human tissue bank study

Jay P. Ciezki, Urs O. Häfeli, Priscilla Song, Nancy Urankar-Nagy, Norman B. Ratliff, Lisa Rybicki, Kevin Brill, Dominik MeierInternational Journal of Radiation Oncology*Biology*Physics 1999 · DOI

TL;DR

This study investigates where cells proliferate in coronary arteries after angioplasty, finding that proliferation occurs throughout the vessel wall, not just near the treated lumen. This insight is crucial for optimizing intravascular brachytherapy, a treatment aimed at preventing restenosis by targeting these proliferating cells.

What Problem Does This Paper Address?

Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure to open blocked coronary arteries. However, a significant challenge is restenosis – the re-narrowing of the artery after the initial treatment. A key contributor to restenosis is the proliferation of cells within the arterial wall. Intravascular brachytherapy, which uses radiation to inhibit this proliferation, has emerged as a promising preventative treatment. However, to effectively apply brachytherapy, it's essential to precisely identify the "target" – the areas where this cellular proliferation is most active. Previous research has focused on the lumen, but this study aims to map the proliferation sites within the entire arterial wall to better guide brachytherapy strategies.

Methods

The researchers utilized a human tissue bank to analyze autopsy samples from patients who had undergone PTCA. They employed immunohistochemical staining for Proliferating Cell Nuclear Antigen (PCNA), a marker for actively dividing cells. To quantify proliferation, they developed a computer-assisted image analysis pipeline. This involved:

  • Image Acquisition: Capturing high-resolution images of arterial cross-sections.
  • Region Segmentation: Dividing each arterial cross-section into three regions based on plaque morphology (thickest, thinnest, and intermediate areas) and also considering different layers (intima, media, adventitia).
  • Color Space Transformation: Converting images from RGB to HSI (Hue, Saturation, Intensity) color space. This was a key step as it allowed for better separation of the brown PCNA staining from the blue hematoxylin counterstain, which is difficult in RGB due to intensity variations.
  • Thresholding: Using intensity and hue thresholds to identify and count all nuclei and then specifically the PCNA-positive nuclei.
  • Proliferation Index (PI) Calculation: Defining the PI as the ratio of positive nuclei to total nuclei, multiplied by 100.

Datasets

The study used autopsy records from The Cleveland Clinic Foundation between January 1, 1985, and December 31, 1995. They identified 64 patients with a history of PTCA and selected 27 whose arterial sections showed evidence of PTCA for detailed analysis. These are human tissue samples, not a curated benchmark dataset.

Key Insights and Ideas

  • Ubiquitous Proliferation: The most striking finding is that cellular proliferation after PTCA isn't confined to the immediate vicinity of the lumen. It occurs throughout the treated arterial section, including the intima, media, and adventitia.
  • Targeting the Adventitia: While not statistically significant due to sample size, there was a trend suggesting the adventitia might be a more active site of proliferation. This is critical for brachytherapy, as delivering adequate radiation doses to the adventitia, especially in eccentric lesions, can be challenging.
  • Younger Lesions Show Higher Proliferation: The study observed a trend where younger lesions (closer to the time of PTCA) exhibited higher proliferation indices. This aligns with the understanding that restenosis is an active process that diminishes over time.

Key Results

  • The proliferation index (PI) did not differ significantly across different arterial regions (plaque, plaque shoulder, or vessel wall with lowest plaque burden) or layers (intima, media, adventitia).
  • There was no significant difference in PI based on whether the patient had prior intervention.
  • A trend suggested the adventitia was a more active site of proliferation (p=0.11).
  • While no statistically significant correlation was found between lesion age and PI, a scatter plot indicated that the highest proliferation indices were observed in lesions that were only a few days old (e.g., 2 days).

Limitations and Future Work

  • Sample Size: The study acknowledges that the sample size was relatively small, which may have limited the statistical power to detect significant differences, particularly for trends like adventitial proliferation.
  • Fixation Time: The exact time between PTCA and tissue fixation was not precisely recorded, and variations in fixation times could confound the analysis of PCNA kinetics, as PCNA has a half-life of over 20 hours. This means conclusions are based on gross localization rather than precise temporal dynamics.
  • Future Work: The authors suggest that future intravascular brachytherapy devices and techniques should be designed to account for the local vascular anatomy, including the eccentric nature of diseased arteries. Vascular imaging techniques like intravascular ultrasound (IVUS) could be valuable for guiding therapy. Additionally, the choice of radiation isotope should consider the need to deliver therapeutic doses through tissue that may be several millimeters from the luminal border.

Summary updated

BibTeX
@article{ciezki1999parenchymal,
  author = {Jay P. Ciezki and Urs O. Häfeli and Priscilla Song and Nancy Urankar-Nagy and Norman B. Ratliff and Lisa Rybicki and Kevin Brill and Dominik Meier},
  title = {{Parenchymal cell proliferation in coronary arteries after percutaneous transluminal coronary angioplasty: a human tissue bank study}},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {1999},
  doi = {10.1016/s0360-3016(99)00261-8},
}
Figure